Drug Profile


Alternative Names: Dexketoprofen trometamol/dicycloverine; Dexketoprofen/dicyclomine; Dicycloverine/dexketoprofen trometamol; DXD; Infen Spas

Latest Information Update: 20 Apr 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Emcure Pharmaceuticals
  • Class Antispasmodics; Nonsteroidal anti-inflammatories; Phenylpropionates; Propylene glycols; Small molecules
  • Mechanism of Action Cyclooxygenase inhibitors; Muscarinic receptor antagonists; S100 protein antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Marketed Acute pain

Most Recent Events

  • 20 Apr 2016 Launched for Acute pain in India (IM) before April 2016
  • 22 Sep 2010 Phase-III clinical trials in Acute pain in India (IM)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top